The group's principal activities are the development, manufacture and distribution of branded prescription pharmaceutical products. The group also provides services to both pharmaceutical and biotechnology companies by designing, manufacturing and compiling patient packs for use un clinical trials, which are then distributed from its facilities in craigavon and Pennsylvania. It also manufactures and supplies intravenous and other sterile solutions, primarily for human use. The group's principal markets are in the United States, the United Kingdom and the republic of Ireland.
